Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Current Leases (2019 - 2026)

Apyx Medical filings provide 7 years of Current Leases readings, the most recent being $407000.0 for Q4 2025.

  • On a quarterly basis, Current Leases rose 21.49% to $407000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $407000.0, a 21.49% increase, with the full-year FY2025 number at $407000.0, up 21.49% from a year prior.
  • Current Leases hit $407000.0 in Q4 2025 for Apyx Medical, up from $393000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $407000.0 in Q4 2025 to a low of $20000.0 in Q3 2023.
  • Median Current Leases over the past 5 years was $120500.0 (2021), compared with a mean of $151350.0.
  • Biggest five-year swings in Current Leases: crashed 94.07% in 2024 and later skyrocketed 1865.0% in 2025.
  • Apyx Medical's Current Leases stood at $165000.0 in 2021, then soared by 30.91% to $216000.0 in 2022, then crashed by 90.74% to $20000.0 in 2023, then surged by 1575.0% to $335000.0 in 2024, then rose by 21.49% to $407000.0 in 2025.
  • The last three reported values for Current Leases were $407000.0 (Q4 2025), $393000.0 (Q3 2025), and $20000.0 (Q2 2025) per Business Quant data.